Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane ActivityXiaolei Bian, Dongliang Guan, Fang Li et al.|Journal of Medicinal Chemistry|2024Cited by 14
A Rationally Designed Sulfonium Lipoglycopeptide with Micelles Self-Assembly to Combat Multidrug Resistance via Dual Enhanced Cell Wall-Membrane Inhibition and T7SS Proteins DownregulationYuanyuan Xie, Dongliang Guan, Xiaowen Wang et al.|Journal of the American Chemical Society|2025Cited by 14
Novel Aryl Sulfonium Modification on Vancomycin to Tackle MRSA and VRE In Vitro and In Vivo through Dual Enhanced Cell-Wall and Membrane InhibitionYuanyuan Xie, Dongliang Guan, Xiaowen Wang et al.|Journal of Medicinal Chemistry|2025Cited by 7
Novel Rationally Designed Lipopeptides Derived from Bacitracin: Combating Multidrug Resistance and Evading Bacitracin Resistance via Potentiated Cell Wall and Membrane InhibitionsSijie Cheng, Dongliang Guan, Jingwen Liao et al.|Journal of Medicinal Chemistry|2025Cited by 4
A Broad-Spectrum Abietane Diterpenoid Derivative that Targets Lipid II Cycle and Bacterial Membrane to Combat Multidrug ResistanceYajing Li, Dongliang Guan, Xiaomei Fu et al.|Journal of Medicinal Chemistry|2025Cited by 4